Stock ALVTX VOLUNTIS S.A.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Voluntis S.A.

Equities

ALVTX

FR0004183960

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Voluntis : announces the success of the Tender Offer initiated by the company Aptar allowing the implementation of mandatory squeeze-out
PU
Voluntis : Voluntis announces the success of the Tender Offer initiated by the company Aptar allowing the implementation of mandatory squeeze-out
AT
Voluntis : Voluntis announces its results for the first half of 2021
AT
Voluntis : announces its results for the first half of 2021
PU
Voluntis : announces the completion of the acquisition by Aptar of a majority stake in Voluntis at a price of €8.70 per share
PU
Voluntis : Voluntis announces the completion of the acquisition by Aptar of a majority stake in Voluntis at a price of EUR 8.70 per share
AT
Voluntis : announces the execution of a Share Purchase Agreement between its reference shareholders and Aptar regarding the acquisition of a majority stake in Voluntis at a price of €8.70 per share
PU
Voluntis : Voluntis announces the execution of a Share Purchase Agreement between its reference shareholders and Aptar regarding the acquisition of a majority stake in Voluntis at a price of EUR 8.70 per share
AT
Voluntis : Exclusive Negotiations Regarding a Potential Acquisition of Voluntis by Aptar to Expand in Digital Therapeutics
AT
Voluntis : Exclusive negotiations regarding a potential acquisition of Voluntis by Aptar to expand in digital therapeutics
PU
Voluntis : Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins
AT
Voluntis : Voluntis receives CE Mark for new version of Oleena with expanded clinical intelligence
AT
Voluntis : Voluntis, a pioneer-turned-leader in digital therapeutics, sets out its ambitions for profitable growth
AT
Voluntis : a pioneer-turned-leader in digital therapeutics, sets out its ambitions for profitable growth
PU
Voluntis : Broward Health and Voluntis Launch a New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast Cancer
BU
Voluntis : Announces the Organization of Meetings With Institutional Investors Accompanied by Brokerage Firm Gilbert Dupont
BU
Voluntis : Strengthens Its Global Customer Support Services in Collaboration With Zendesk
BU
Voluntis : Publication of a New Study on Voluntis by Brokerage Firm Bryan, Garnier & Co
BU
Voluntis: Initiation of Voluntis Stock Coverage by the Brokerage Firm Gilbert Dupont
BU
Voluntis : First day of trading of Voluntis shares on the Euronext Growth Paris market
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALVTX Stock
  4. News Voluntis S.A.
  5. Press Releases